3 line items for clonidine patches. Awarded for a base year of 11/30/2025 to 11/29/2026.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0054
- Awardee
-
Mylan Pharmaceuticals Inc. UEI NDN1MYB8DKK5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Clonidine Patches Pre-Solicitation · 36E79725R0037 · Posted Apr 28, 2025
- Last date to order 88% complete
- IDV ceiling
- $6,244,458.40
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Mylan Pharmaceuticals Inc. for clonidine patches with a ceiling of $6,244,458.40, effective November 30, 2025. The contract carries a base year running through November 29, 2026, with a stated ultimate completion date of November 29, 2026.
The solicitation, issued in commercial item format in May 2025, targeted three line items for clonidine patches (0.1mg, 0.2mg, and 0.3mg formulations) to be distributed across the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center through VA and DoD Pharmaceutical Prime Vendor Programs. Estimated annual usage comprised 28,788 bottles of 0.1mg patches, 32,468 bottles of 0.2mg patches, and 36,204 bottles of 0.3mg patches. Evaluation criteria emphasized uninterrupted supply capability, compliance with specified labeling requirements (unique NDC number, single label), and precise pharmaceutical specifications. The contract uses NAICS code 325412 for Pharmaceutical Preparation Manufacturing.
A modification incorporating Executive Order 14398 clause 52.222-90 was incorporated into the contract post-award. The solicitation anticipated a base year plus four pre-priced one-year option periods, though the source does not indicate option exercise.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0054?
36E79725D0054 was awarded to Mylan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on November 30, 2025.
How much is contract 36E79725D0054 worth?
36E79725D0054's own ceiling is $6,244,458.
Who can order from contract 36E79725D0054?
36E79725D0054 is a single award indefinite delivery contract.
Was contract 36E79725D0054 competed?
The extent of competition for 36E79725D0054 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV